对2型糖尿病患者的Tr1淋巴细胞进行定量分析
C Knott-Torcal1,2, N S de la Blanca1, A Serrano-Somavilla1
1Department of Endocrinology and Nutrition, Health Research Institute, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, C/Diego de León 62, 28006, Madrid, Spain.
Journal of endocrinological investigation
|January 6, 2024
概括
2型糖尿病 (T2DM) 与1型调节细胞 (Tr1) 的增加有关. 用葡萄糖类-1受体激活剂 (GLP-1-RA) 治疗可能会使T2DM患者的Tr1细胞水平正常化.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 2型糖尿病 (T2DM) 与慢性低度炎症有关,这是其并发症的关键因素.
- 调节性T (Treg) 淋巴细胞调节炎症反应,但1型T调节性 (Tr1) 细胞在T2DM中的作用仍然未被探索.
研究的目的:
- 量化T2DM患者的Tr1淋巴细胞和其他免疫细胞子集.
- 为了将免疫细胞水平与T2DM中的临床参数和治疗相关联.
主要方法:
- 多参数流细胞计用于分析周边血液样本.
- 研究的细胞子集包括Tr1 (CD4+CD49+LAG-3+IL-10+),Th17,Th22和Foxp3+Treg细胞.
- 将60名T2DM患者与23名健康对照进行了比较,评估了生物化学和人类学变量.
主要成果:
- 在T2DM患者中,Tr1细胞和CD4+IL-10+淋巴细胞在疾病严重程度上显著升高.
- 患者和对照组之间Foxp3+ Treg,Th17和Th22细胞水平没有差异.
- 与健康对照组相比,接受GLP-1受体激活剂 (GLP-1-RA) 治疗的患者表现出正常化的Tr1细胞水平,与未接受治疗的T2DM患者相比,水平较低.
结论:
- T2DM的特征是Tr1和CD4+IL-10+淋巴细胞水平增加,这表明潜在的免疫功能障碍.
- GLP-1-RA治疗与Tr1细胞计数的正常化有显著的关联.
- 这些发现表明T2DM发病过程中存在一种新的免疫路径,以及GLP-1-RA对免疫调节的潜在治疗作用.
更多相关视频
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
2.6K
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
14.6K
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
